Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|July 20, 2006
Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancerCharles Spruck, Dahui Sun, Heidi Fiegl, et al.
Breast Cancer Research and Treatment|February 24, 2007
Ultrasound-guided core needle biopsy of the breast: does frozen section give an accurate diagnosis?Elisabeth Mueller-Holzner, Thomas Frede, Martin Daniaux, et al.
Water Research|April 11, 2013
Fate and transformation of silver nanoparticles in urban wastewater systemsRalf Kaegi, Andreas Voegelin, Christoph Ort, et al.
Cancer Research|March 1, 2005
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsHeidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, et al.
Gynecologic Oncology|April 16, 2003
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastasesNicole Concin, Lukas Hefler, Jeroen van Bavel, et al.
BMJ Open|May 16, 2025
Application of diagnostic criteria in paediatric complex regional pain syndrome: a scoping review protocolSee Wan Tham, Rebecca Lee, Lisa-Marie Rau, et al.
Studies in Health Technology and Informatics|August 28, 2014
A concept of a MIABIS based register of biosample collections at the Medical University of InnsbruckPhilipp Hofer, Heidi Fiegl, Justina Angerer, et al.
Gynecologic Oncology|April 22, 2004
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancerAndreas Widschwendter, Hannes M Müller, Michael M Hubalek, et al.
Gynecologic Oncology|January 22, 2011
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancerAlain G Zeimet, Heidi Fiegl, Georg Goebel, et al.
Gynecologic Oncology|May 9, 2006
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancerGilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Pageof 5